SCHEMBL29331768

SCHEMBL29331768

CC1C[C@@H](CO[P@](=O)(S)O[C@@H]2C[C@@H](CO[P@@](=O)(O)S)O[C@H]2n2c(=O)[nH]c3c(N)ncnc32)O[C@H]1n1cnc2c(N)ncnc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DTYMK P23919 2/20 0.44
▸ P2RY1 P47900 4/20 0.44
▸ P2RY2 P41231 3/20 0.44
▸ SRC P12931 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ DNPH1 O43598 1/20 0.44
▸ PRKAB2 O43741 1/20 0.44
▸ TRPM2 O94759 1/20 0.44
▸ LDHA P00338 1/20 0.44
▸ ADRB2 P07550 1/20 0.44
▸ FBP1 P09467 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ PRKAG1 P54619 1/20 0.44
▸ PRKAA2 P54646 1/20 0.44
▸ PDE4D Q08499 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ PRKAA1 Q13131 1/20 0.44
▸ PDE3A Q14432 1/20 0.44
▸ TAS1R3 Q7RTX0 1/20 0.44
▸ TAS1R1 Q7RTX1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21896050 0.92 DTYMK (0.47) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29325801 0.85 FHIT (0.44) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29324032 0.84 DTYMK (0.45) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29325781 0.83 DTYMK (0.41) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29331766 0.82 DTYMK (0.41) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL23679552 0.82 DTYMK (0.42) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL23679635 0.81 P2RY1 (0.42) DTYMKP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL23679562 0.80 RNASEL (0.49) P2RY1P2RY2SRCSMN1; SMN2DNPH1
SCHEMBL20692029 0.79 FHIT (0.48) P2RY1P2RY2SRCSMN1; SMN2DNPH1
SCHEMBL23679565 0.79 AMD1 (0.42) DTYMKP2RY1P2RY2SRCSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3854799-B1 CYCLIC DINUCLEOTIDE ANALOGUE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION SHANGHAI DE NOVO PHARMATECH CO LTD (CN) 2024-07-17 — — EP disclosed
Send feedback